Using polygenic and transcriptional risk scores to investigate psychiatric and cognitive symptoms in Parkinson's disease
medRxiv 2025.03.20.25324166; doi: https://doi.org/10.1101/2025.03.20.25324166
Preprint
Mar 20, 2025